Multiple endocrine neoplasia type 1 primary prevention: Difference between revisions
(Mahshid) |
|||
(2 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
{{Multiple endocrine neoplasia type 1}} | {{Multiple endocrine neoplasia type 1}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
Line 9: | Line 7: | ||
==Primary Prevention== | ==Primary Prevention== | ||
There is no established method for the prevention of the [[MEN-1]] | |||
==References== | ==References== | ||
Line 18: | Line 17: | ||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Surgery]] |
Latest revision as of 02:45, 27 November 2017
Multiple endocrine neoplasia type 1 Microchapters |
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Multiple endocrine neoplasia type 1 primary prevention On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 primary prevention |
FDA on Multiple endocrine neoplasia type 1 primary prevention |
CDC on Multiple endocrine neoplasia type 1 primary prevention |
Multiple endocrine neoplasia type 1 primary prevention in the news |
Blogs on Multiple endocrine neoplasia type 1 primary prevention |
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is no established method for prevention of Multiple endocrine neoplasia-1 (MEN-1)
Primary Prevention
There is no established method for the prevention of the MEN-1